Anika Therapeutics, Inc. (ANIK)

CIK 898437 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anika Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 20261440001959173-26-005793
Aug 5, 202640001193125-26-335269
Jul 31, 2026SCHEDULE 13G/A0002100119-26-001342
Jul 29, 20268-K0001171843-26-004977
Jul 29, 2026S-80001171843-26-005017
Jul 29, 202610-Q0001171843-26-005012
Jul 17, 2026SCHEDULE 13G/A0002052113-26-000740
Jul 14, 20268-K0001171843-26-004635
Jun 23, 20268-K0001171843-26-004253
Jun 23, 202640001193125-26-279545
Jun 23, 202640001193125-26-279535
Jun 23, 202640001193125-26-279542
Jun 23, 202640001193125-26-279541
Jun 23, 202640001193125-26-279539
Jun 8, 2026DEFA14A0001140361-26-024374
Jun 5, 202640001193125-26-259520
Jun 1, 2026DEFA14A0001140361-26-023475
May 4, 202640001193125-26-202704
Apr 30, 202610-Q0001171843-26-002852
Apr 30, 202640001193125-26-197887
Apr 29, 20268-K0001171843-26-002799
Apr 29, 2026SCHEDULE 13G0002100119-26-000113
Apr 28, 2026DEF 14A0001140361-26-017488
Apr 28, 2026DEFA14A0001140361-26-017489
Apr 28, 2026ARS0001140361-26-017490